Dr. Gary E. Fraser, MD

Dr. Fraser practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Fraser's NPI, 1265454672, was assigned on July 24, 2006. Dr. Fraser graduated from University of Otago School of Medicine in 1969. Dr. Fraser holds California license A33706.

Dr. Fraser's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Fraser's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Fraser to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fraser practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Fraser's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Fraser is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Fraser's licenses on file in 2 states: California and Minnesota.

Dmand AI lists cardiomyopathy, chronic hypertension, coronary artery disease, heart failure and heart valve disorders among the conditions Dr. Fraser treats.

CMS data shows 187 Medicare services from Dr. Fraser across 5 procedure codes in 2024, for 221 Medicare patients. Medicare paid $5,520 for them.

CMS counts 221 Medicare patients who saw Dr. Fraser in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fraser's median patient age at 63, with 57% women.

In 2024, Dr. Fraser wrote 230 Medicare Part D claims for 59 patients. 76% of them were for generic drugs. CMS names the drug for 147 of them, across 8 drugs with 11 or more claims each, at $31,626 in total drug cost. In 2023, CMS named 172 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fraser for performance year 2024, reported as part of a group. Dr. Fraser accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 196 papers to Dr. Fraser, published from 2006 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Diet, Diet, Vegetarian and Body Mass Index. Dr. Fraser has published most often in Am J Clin Nutr. Dr. Fraser's most frequent co-authors are Michael John Orlich, MD, Serena Tonstad and Dmitry Abramov, MD.

Dmand AI links Dr. Fraser to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Rectal Diseases and Colorectal Neoplasms.

CMS Open Payments shows 3 general payments to Dr. Fraser from 3 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 79% of the total. Covidien LP paid the most, $193.

Dmand AI lists 8 awards for Dr. Fraser, most recently Distinguished Professor of Epidemiology in 2020.

Dr. Fraser graduated from University of Otago School of Medicine in 1969. Dr. Fraser is a member of ACC.

Dr. Fraser is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.